Prospective Evaluation of Community‐Acquired Acute‐Phase Hepatitis C Virus Infection
Author(s) -
Andrea L. Cox,
Dale Netski,
Timothy L. Mosbruger,
Susan G. Sherman,
Steffanie A. Strathdee,
Danielle C. Ompad,
David Vlahov,
David Chien,
Venkatakrishna Shyamala,
Stuart C. Ray,
David L. Thomas
Publication year - 2005
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/428578
Subject(s) - seroconversion , viremia , medicine , hepatitis c virus , asymptomatic , alanine transaminase , hepatitis c , immunology , prospective cohort study , jaundice , viral disease , gastroenterology , flaviviridae , virology , hepacivirus , viral load , antibody , virus
More than two-thirds of hepatitis C virus (HCV) infections in Western countries are caused by injection drug use, but prospective clinical data regarding the most common mode of HCV acquisition are rare, in part because acute-phase HCV infection is usually asymptomatic.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom